Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 331

1.

Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicine.

Voss CY, Albertini MR, Malter JS.

Transfus Med Rev. 2004 Jul;18(3):189-202. Review.

PMID:
15248169
2.

Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.

Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.

Clin Cancer Res. 2005 Nov 1;11(21):7891-900.

3.

Dendritic cell-based treatment of cancer: closing in on a cellular therapy.

Valone FH, Small E, MacKenzie M, Burch P, Lacy M, Peshwa MV, Laus R.

Cancer J. 2001 Nov-Dec;7 Suppl 2:S53-61.

PMID:
11777265
4.

Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.

Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, Nair S, Gilboa E.

Clin Cancer Res. 2005 Aug 1;11(15):5566-71.

5.

The use of dendritic cells for cancer vaccination.

Esche C, Shurin MR, Lotze MT.

Curr Opin Mol Ther. 1999 Feb;1(1):72-81. Review.

PMID:
11249687
6.

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

Cannon MJ, O'Brien TJ, Underwood LJ, Crew MD, Bondurant KL, Santin AD.

Expert Rev Anticancer Ther. 2002 Feb;2(1):97-105. Review.

PMID:
12113075
7.

The use of dendritic cells in cancer immunotherapy.

Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P.

Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9. Epub 2007 Dec 4. Review.

PMID:
18055210
8.

Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.

Suzuki T, Fukuhara T, Tanaka M, Nakamura A, Akiyama K, Sakakibara T, Koinuma D, Kikuchi T, Tazawa R, Maemondo M, Hagiwara K, Saijo Y, Nukiwa T.

Clin Cancer Res. 2005 Jan 1;11(1):58-66.

9.
10.

Current approaches in dendritic cell generation and future implications for cancer immunotherapy.

Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K, Thielemans K, Bonehill A.

Cancer Immunol Immunother. 2007 Oct;56(10):1513-37. Epub 2007 May 15. Review.

PMID:
17503040
11.

[Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].

Rossowska J, Pajtasz-Piasecka E.

Postepy Hig Med Dosw. 2003;57(5):501-18. Review. Polish.

PMID:
14737967
12.

Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.

Delcayre A, Shu H, Le Pecq JB.

Expert Rev Anticancer Ther. 2005 Jun;5(3):537-47. Review.

PMID:
16001959
13.

Clinical applications of dendritic cell vaccines.

Morse MA, Lyerly HK.

Curr Opin Mol Ther. 2000 Feb;2(1):20-8. Review.

PMID:
11249649
14.

Dendritic cells in tumor immunology and immunotherapy.

Turtle CJ, Hart DN.

Curr Drug Targets. 2004 Jan;5(1):17-39. Review.

PMID:
14738216
15.

Generation of dendritic cell-based vaccines for cancer therapy.

Reinhard G, Märten A, Kiske SM, Feil F, Bieber T, Schmidt-Wolf IG.

Br J Cancer. 2002 May 20;86(10):1529-33. Review.

16.

Immunotherapy with dendritic cells for cancer.

Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A.

Adv Drug Deliv Rev. 2008 Jan 14;60(2):173-83. Epub 2007 Oct 5. Review.

PMID:
17977615
17.

Gene-based strategies for the immunotherapy of cancer.

Tüting T, Storkus WJ, Lotze MT.

J Mol Med (Berl). 1997 Jul;75(7):478-91. Review.

PMID:
9253711
18.

Cell fusion: from hybridoma to dendritic cell-based vaccine.

Gong J, Koido S, Calderwood SK.

Expert Rev Vaccines. 2008 Sep;7(7):1055-68. doi: 10.1586/14760584.7.7.1055. Review.

PMID:
18767954
19.

Current developments in cancer vaccines and cellular immunotherapy.

Ribas A, Butterfield LH, Glaspy JA, Economou JS.

J Clin Oncol. 2003 Jun 15;21(12):2415-32. Review.

PMID:
12805342
20.

Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.

Eur Urol. 2008 Apr;53(4):694-708. Epub 2007 Nov 26. Review.

PMID:
18061335

Supplemental Content

Support Center